Home/Sutro Biopharma/Lawrence Fong
LF

Lawrence Fong

Member, Scientific Advisory Board; Co-Chair, Clinical Advisory Board

Sutro Biopharma

Roles

Member, Scientific Advisory Board; Co-Chair, Clinical Advisory BoardatSutro Biopharma
Scientific Advisor, Cancer Immunotherapy Program, UCSFatBioAtla

Therapeutic Areas

Sutro Biopharma Pipeline

DrugIndicationPhase
Luveltamab tazevibulin (STRO-002)Folate receptor-alpha (FolRα) expressing ovarian cancerPhase 2/3
STRO-003ROR1-expressing solid tumorsPreclinical
Next-generation ADCsUndisclosed cancersDiscovery/Preclinical
Cytokine-based Immuno-oncologyUndisclosed cancersResearch